Radiogenomics models in precision radiotherapy: from mechanistic to machine learning

Machine learning provides a broad framework for addressing high-dimensional prediction problems in classification and regression. While machine learning is often applied for imaging problems in medical physics, there are many efforts to apply these principles to biological data towards questions of radiation biology. Here, we provide a review of radiogenomics modeling frameworks and efforts towards genomically-guided radiotherapy. We first discuss medical oncology efforts to develop precision biomarkers. We next discuss similar efforts to create clinical assays for normal tissue or tumor radiosensitivity. We then discuss modeling frameworks for radiosensitivity and the evolution of machine learning to create predictive models for radiogenomics.

[1]  J. Hendry,et al.  Radiobiology for the Radiologist , 1979, British Journal of Cancer.

[2]  M. Goitein,et al.  Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.

[3]  H D Thames,et al.  Evidence for individual differences in the radiosensitivity of human skin. , 1992, European journal of cancer.

[4]  Lawrence D. Jackel,et al.  Learning Curves: Asymptotic Values and Rate of Convergence , 1993, NIPS.

[5]  J. Overgaard,et al.  Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity. , 1993, European journal of cancer.

[6]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[7]  R. Tibshirani Regression Shrinkage and Selection via the Lasso , 1996 .

[8]  Ron Kohavi,et al.  Wrappers for Feature Subset Selection , 1997, Artif. Intell..

[9]  G.E. Moore,et al.  Cramming More Components Onto Integrated Circuits , 1998, Proceedings of the IEEE.

[10]  M. Opper,et al.  Statistical mechanics of Support Vector networks. , 1998, cond-mat/9811421.

[11]  Arthur E. Hoerl,et al.  Ridge Regression: Biased Estimation for Nonorthogonal Problems , 2000, Technometrics.

[12]  Jonathan A C Sterne,et al.  Sifting the evidence—what's wrong with significance tests? , 2001, BMJ : British Medical Journal.

[13]  Leo Breiman,et al.  Statistical Modeling: The Two Cultures (with comments and a rejoinder by the author) , 2001 .

[14]  H. Cordell Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. , 2002, Human molecular genetics.

[15]  C. Begg,et al.  Two‐Stage Designs for Gene–Disease Association Studies , 2002, Biometrics.

[16]  J. Hendry,et al.  Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy. , 2002, International journal of radiation oncology, biology, physics.

[17]  Sunil J Rao,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2003 .

[18]  Sayan Mukherjee,et al.  Estimating Dataset Size Requirements for Classifying DNA Microarray Data , 2003, J. Comput. Biol..

[19]  Isabelle Guyon,et al.  An Introduction to Variable and Feature Selection , 2003, J. Mach. Learn. Res..

[20]  M. Cronin,et al.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.

[21]  K. Lunetta,et al.  Screening large-scale association study data: exploiting interactions using random forests , 2004, BMC Genetics.

[22]  Larry Wasserman,et al.  All of Statistics: A Concise Course in Statistical Inference , 2004 .

[23]  H. Zou,et al.  Regularization and variable selection via the elastic net , 2005 .

[24]  R. Mirimanoff,et al.  MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.

[25]  Joos V Lebesque,et al.  Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling. , 2006, International journal of radiation oncology, biology, physics.

[26]  D. Reich,et al.  Population Structure and Eigenanalysis , 2006, PLoS genetics.

[27]  William Stafford Noble,et al.  Support vector machine , 2013 .

[28]  I El Naqa,et al.  Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose–volume outcome relationships , 2006, Physics in medicine and biology.

[29]  Jianqing Fan,et al.  Sure independence screening for ultrahigh dimensional feature space , 2006, math/0612857.

[30]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[31]  J. Deasy,et al.  Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters. , 2006, International journal of radiation oncology, biology, physics.

[32]  Christopher M. Bishop,et al.  Pattern Recognition and Machine Learning (Information Science and Statistics) , 2006 .

[33]  N G Burnet,et al.  Radiosensitivity, radiogenomics and RAPPER. , 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

[34]  G. Moore Cramming more components onto integrated circuits, Reprinted from Electronics, volume 38, number 8, April 19, 1965, pp.114 ff. , 2006, IEEE Solid-State Circuits Newsletter.

[35]  G. Abecasis,et al.  Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies , 2006, Nature Genetics.

[36]  R. Tibshirani,et al.  "Preconditioning" for feature selection and regression in high-dimensional problems , 2007, math/0703858.

[37]  G. Abecasis,et al.  Optimal designs for two‐stage genome‐wide association studies , 2007, Genetic epidemiology.

[38]  Geoffrey E. Hinton,et al.  Visualizing Data using t-SNE , 2008 .

[39]  G. Clark,et al.  Prognostic factors versus predictive factors: Examples from a clinical trial of erlotinib , 2008, Molecular oncology.

[40]  Sun I. Kim,et al.  Nonlinear Support Vector Machine Visualization for Risk Factor Analysis Using Nomograms and Localized Radial Basis Function Kernels , 2008, IEEE Transactions on Information Technology in Biomedicine.

[41]  Radhe Mohan,et al.  Analysis of radiation pneumonitis risk using a generalized Lyman model. , 2008, International journal of radiation oncology, biology, physics.

[42]  N. Meinshausen,et al.  Stability selection , 2008, 0809.2932.

[43]  Yichao Wu,et al.  Ultrahigh Dimensional Feature Selection: Beyond The Linear Model , 2009, J. Mach. Learn. Res..

[44]  L. Wasserman,et al.  HIGH DIMENSIONAL VARIABLE SELECTION. , 2007, Annals of statistics.

[45]  Jason H. Moore,et al.  Spatially Uniform ReliefF (SURF) for computationally-efficient filtering of gene-gene interactions , 2009, BioData Mining.

[46]  J. Alsner,et al.  Genetic variants and normal tissue toxicity after radiotherapy: a systematic review. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[47]  Trevor J. Hastie,et al.  Genome-wide association analysis by lasso penalized logistic regression , 2009, Bioinform..

[48]  Ananya Choudhury,et al.  MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer. , 2010, Cancer research.

[49]  Joseph O Deasy,et al.  Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. , 2010, International journal of radiation oncology, biology, physics.

[50]  Stephen J O'Brien,et al.  Accounting for multiple comparisons in a genome-wide association study (GWAS) , 2010, BMC Genomics.

[51]  K. Roeder,et al.  Screen and clean: a tool for identifying interactions in genome‐wide association studies , 2010, Genetic epidemiology.

[52]  Patrick F. Sullivan,et al.  A quality control algorithm for filtering SNPs in genome-wide association studies , 2010, Bioinform..

[53]  Barry S Rosenstein,et al.  Establishment of a radiogenomics consortium. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[54]  Asako Koike,et al.  SNPInterForest: A new method for detecting epistatic interactions , 2011, BMC Bioinformatics.

[55]  E. Boerwinkle,et al.  Mining gold dust under the genome wide significance level: a two‐stage approach to analysis of GWAS , 2011, Genetic epidemiology.

[56]  Satish Chikkagoudar,et al.  Ranking causal variants and associated regions in genome-wide association studies by the support vector machine and random forest , 2011, Nucleic acids research.

[57]  Jean Yee Hwa Yang,et al.  Gene-gene interaction filtering with ensemble of filters , 2011, BMC Bioinformatics.

[58]  Rongling Li,et al.  Quality Control Procedures for Genome‐Wide Association Studies , 2011, Current protocols in human genetics.

[59]  Xin Wang,et al.  SNP interaction detection with Random Forests in high-dimensional genetic data , 2012, BMC Bioinformatics.

[60]  Annette M. Molinaro,et al.  Power of Data Mining Methods to Detect Genetic Associations and Interactions , 2011, Human Heredity.

[61]  Joseph O Deasy,et al.  A Bayesian network approach for modeling local failure in lung cancer , 2011, Physics in medicine and biology.

[62]  Suzanne L Wolden,et al.  Radiation-induced micro-RNA expression changes in peripheral blood cells of radiotherapy patients. , 2011, International journal of radiation oncology, biology, physics.

[63]  Q. Wei,et al.  Functional promoter rs2868371 variant of HSPB1 associates with radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with radio(chemo)therapy. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[64]  A. Italiano,et al.  Prognostic or predictive? It's time to get back to definitions! , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[65]  Yudi Pawitan,et al.  Validation of a Radiosensitivity Molecular Signature in Breast Cancer , 2012, Clinical Cancer Research.

[66]  Arndt Hartmann,et al.  Expression of TIP60 (tat‐interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment‐specific outcome of localised invasive bladder cancer , 2012, BJU international.

[67]  J. Torres-Roca,et al.  A molecular assay of tumor radiosensitivity: a roadmap towards biology-based personalized radiation therapy. , 2012, Personalized medicine.

[68]  M. Sydes,et al.  Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study. , 2012, The Lancet. Oncology.

[69]  Daniel Gomez,et al.  Association between single nucleotide polymorphisms of the transforming growth factor β1 gene and the risk of severe radiation esophagitis in patients with lung cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[70]  Joos V Lebesque,et al.  The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancer. , 2012, International journal of radiation oncology, biology, physics.

[71]  Andrea Ottolenghi,et al.  Biological mechanisms of normal tissue damage: importance for the design of NTCP models. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[72]  X. Chen,et al.  Random forests for genomic data analysis. , 2012, Genomics.

[73]  J Chang-Claude,et al.  A replicated association between polymorphisms near TNFα and risk for adverse reactions to radiotherapy , 2012, British Journal of Cancer.

[74]  J. Ogutu,et al.  Genomic selection using regularized linear regression models: ridge regression, lasso, elastic net and their extensions , 2012, BMC Proceedings.

[75]  Petra Seibold,et al.  Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[76]  Radhe Mohan,et al.  Functional promoter variant rs2868371 of HSPB1 is associated with risk of radiation pneumonitis after chemoradiation for non-small cell lung cancer. , 2013, International journal of radiation oncology, biology, physics.

[77]  Radhe Mohan,et al.  Incorporating single-nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis. , 2013, International journal of radiation oncology, biology, physics.

[78]  Jim Davies,et al.  Data-driven Markov models and their application in the evaluation of adverse events in radiotherapy , 2013, Journal of radiation research.

[79]  J. Beck,et al.  Cancer Patients’ Trade-offs Among Efficacy, Toxicity, and Out-of-Pocket Cost in the Curative and Noncurative Setting , 2013, Medical care.

[80]  C. Belka,et al.  Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients , 2013, Radiation Oncology.

[81]  James J. Gallagher,et al.  Reply to , 2014 .

[82]  Alison M Dunning,et al.  A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1 , 2014, Nature Genetics.

[83]  S. Eschrich,et al.  A gene expression platform to predict benefit from adjuvant external beam radiation in resected non-small cell lung cancer , 2014, medRxiv.

[84]  T. Salakoski,et al.  Regularized Machine Learning in the Genetic Prediction of Complex Traits , 2014, PLoS genetics.

[85]  Chris S. Haley,et al.  Detecting epistasis in human complex traits , 2014, Nature Reviews Genetics.

[86]  S. Eschrich,et al.  A Molecular Signature of Radiosensitivity (RSI) is an RT-specific Biomarker in Prostate Cancer , 2014 .

[87]  T. Ørntoft,et al.  Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[88]  J. Chang-Claude,et al.  XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients. , 2015, International journal of radiation oncology, biology, physics.

[89]  P. Zandi,et al.  Whole-genome CNV analysis: advances in computational approaches , 2015, Front. Genet..

[90]  Jeffrey D Bradley,et al.  Bayesian network ensemble as a multivariate strategy to predict radiation pneumonitis risk. , 2015, Medical physics.

[91]  Issam El Naqa,et al.  Contrasting analytical and data-driven frameworks for radiogenomic modeling of normal tissue toxicities in prostate cancer. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[92]  Martin J. Murphy,et al.  Machine Learning in Radiation Oncology , 2015 .

[93]  Jason H Moore,et al.  Epistasis analysis using ReliefF. , 2015, Methods in molecular biology.

[94]  J. R. MacDonald,et al.  A copy number variation map of the human genome , 2015, Nature Reviews Genetics.

[95]  K. Ballman,et al.  Biomarker: Predictive or Prognostic? , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[96]  Mufaddal Mamawala,et al.  Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[97]  J. Flickinger,et al.  Machine Learning Approaches for Predicting Radiation Therapy Outcomes: A Clinician's Perspective. , 2015, International journal of radiation oncology, biology, physics.

[98]  James Coates,et al.  Motivation for the inclusion of genetic risk factors of radiosensitivity alongside dosimetric and clinical parameters in predicting normal tissue effects , 2015, Acta oncologica.

[99]  William Stafford Noble,et al.  Machine learning applications in genetics and genomics , 2015, Nature Reviews Genetics.

[100]  Venkat Reddy Konasani,et al.  Multiple Regression Analysis , 2015 .

[101]  B. Vogelstein,et al.  PD-1 blockade in tumors with mismatch repair deficiency. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[102]  Gaetano Rocco,et al.  Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[103]  Virginia G Kaklamani,et al.  Prospective Validation of a 21-Gene Expression Assay in Breast Cancer. , 2015, The New England journal of medicine.

[104]  Felix Y. Feng,et al.  Development and Validation of a Novel Radiosensitivity Signature in Human Breast Cancer , 2015, Clinical Cancer Research.

[105]  A. Nahum,et al.  The performance of normal-tissue complication probability models in the presence of confounding factors. , 2015, Medical physics.

[106]  Johannes Gehrke,et al.  Intelligible Models for HealthCare: Predicting Pneumonia Risk and Hospital 30-day Readmission , 2015, KDD.

[107]  R. Stupp,et al.  Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter--still a dilemma? , 2015, Neuro-oncology.

[108]  Honghao Zhou,et al.  Radiogenomics helps to achieve personalized therapy by evaluating patient responses to radiation treatment. , 2015, Carcinogenesis.

[109]  Qingyao Wu,et al.  Genome-wide association data classification and SNPs selection using two-stage quality-based Random Forests , 2015, BMC Genomics.

[110]  E. Basch,et al.  Patient-reported outcomes in the evaluation of toxicity of anticancer treatments , 2016, Nature Reviews Clinical Oncology.

[111]  Martin Wattenberg,et al.  How to Use t-SNE Effectively , 2016 .

[112]  Petra Seibold,et al.  Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[113]  Adam P Dicker,et al.  Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis. , 2016, The Lancet. Oncology.

[114]  P. Tamayo,et al.  A genetic basis for the variation in the vulnerability of cancer to DNA damage , 2016, Nature Communications.

[115]  William S Bush,et al.  Are Interactions between cis-Regulatory Variants Evidence for Biological Epistasis or Statistical Artifacts? , 2016, American journal of human genetics.

[116]  M. Atkinson,et al.  MicroRNAs as novel elements in personalized radiotherapy , 2016 .

[117]  L. Ungar,et al.  MediBoost: a Patient Stratification Tool for Interpretable Decision Making in the Era of Precision Medicine , 2016, Scientific Reports.

[118]  Gilles Blanchard,et al.  Combining Multiple Hypothesis Testing with Machine Learning Increases the Statistical Power of Genome-wide Association Studies , 2016, Scientific Reports.

[119]  Christian Nicolaj Andreassen,et al.  Radiogenomics - current status, challenges and future directions. , 2016, Cancer letters.

[120]  Issam El Naqa,et al.  Big Data Analytics for Prostate Radiotherapy , 2016, Front. Oncol..

[121]  Mechthild Krause,et al.  Radiation oncology in the era of precision medicine , 2016, Nature Reviews Cancer.

[122]  Joseph O. Deasy,et al.  Computational methods using genome-wide association studies to predict radiotherapy complications and to identify correlative molecular processes , 2017, Scientific Reports.

[123]  A. Chen,et al.  Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH. , 2017, Current problems in cancer.

[124]  D. Shin,et al.  Poster ViewingCirculating Pre-treatment miRNAs as Potential Biomarkers to Predict Radiation Toxicity , 2017 .

[125]  M. Kraemer,et al.  A survey of patient and physician acceptance of skin toxicities from anti-epidermal growth factor receptor therapies , 2017, Supportive Care in Cancer.

[126]  Mykel J. Kochenderfer,et al.  Learning Discrete Bayesian Networks from Continuous Data , 2015, J. Artif. Intell. Res..

[127]  C. Simone,et al.  Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline. , 2017, Practical radiation oncology.

[128]  D. Osoba,et al.  Short‐Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma , 2017, The New England journal of medicine.

[129]  D. Spratt,et al.  Genomic-adjusted radiation dose. , 2017, The Lancet. Oncology.

[130]  S. Jolly,et al.  Unraveling biophysical interactions of radiation pneumonitis in non-small-cell lung cancer via Bayesian network analysis. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[131]  Issam El Naqa,et al.  Radiogenomics and radiotherapy response modeling , 2017, Physics in medicine and biology.

[132]  Gonçalo R. Abecasis,et al.  GAS Power Calculator: web-based power calculator for genetic association studies , 2017, bioRxiv.

[133]  Jacob G. Scott,et al.  A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study. , 2017, The Lancet. Oncology.

[134]  Wentian Li,et al.  Application of t-SNE to Human Genetic Data , 2017, bioRxiv.

[135]  D. Matei,et al.  A randomized phase III trial of cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel vs. carboplatin and paclitaxel for optimally debulked, advanced endometrial carcinoma. , 2017 .

[136]  B. Rosenstein Radiogenomics: Identification of Genomic Predictors for Radiation Toxicity. , 2017, Seminars in radiation oncology.

[137]  W. Woodward,et al.  Association of Transforming Growth Factor &bgr; Polymorphism C−509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial , 2018, JAMA oncology.

[138]  A. Tafreshi,et al.  Pembrolizumab plus Chemotherapy for Squamous Non–Small‐Cell Lung Cancer , 2018, The New England journal of medicine.

[139]  Suneetha Uppu,et al.  A Review on Methods for Detecting SNP Interactions in High-Dimensional Genomic Data , 2018, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[140]  Jean L Wright,et al.  Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. , 2018, Practical radiation oncology.

[141]  Timothy D. Solberg,et al.  Machine Learning in Radiation Oncology: Opportunities, Requirements, and Needs , 2018, Front. Oncol..

[142]  S. Novello,et al.  Pembrolizumab plus Chemotherapy in Metastatic Non–Small‐Cell Lung Cancer , 2018, The New England journal of medicine.

[143]  R. Epstein,et al.  Willingness to bear adversity and beliefs about the curability of advanced cancer. , 2018, Journal of Clinical Oncology.

[144]  Jacob G. Scott,et al.  Machine Learning and Radiogenomics: Lessons Learned and Future Directions , 2018, Front. Oncol..

[145]  D. Spratt Ki-67 Remains Solely a Prognostic Biomarker in Localized Prostate Cancer. , 2018, International journal of radiation oncology, biology, physics.

[146]  Gilmer Valdes,et al.  Artificial intelligence in radiation oncology: A specialty-wide disruptive transformation? , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[147]  S. Jolly,et al.  Serum MicroRNA Signature Predicts Response to High-Dose Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer. , 2018, International journal of radiation oncology, biology, physics.

[148]  D Ruan,et al.  Treatment data and technical process challenges for practical big data efforts in radiation oncology , 2018, Medical physics.

[149]  C. N. Coleman,et al.  Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference. , 2017, International journal of radiation oncology, biology, physics.

[150]  Issam El Naqa,et al.  A multiobjective Bayesian networks approach for joint prediction of tumor local control and radiation pneumonitis in nonsmall‐cell lung cancer (NSCLC) for response‐adapted radiotherapy , 2018, Medical physics.

[151]  Elena Rojano,et al.  Analyzing the Effects of Genetic Variation in Noncoding Genomic Regions , 2018 .

[152]  K. Hoffman,et al.  Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline. , 2018, Practical radiation oncology.

[153]  K. Brock,et al.  On the Fuzziness of Machine Learning, Neural Networks, and Artificial Intelligence in Radiation Oncology. , 2018, International journal of radiation oncology, biology, physics.

[154]  Issam El Naqa,et al.  Single- and Multi-Fraction Stereotactic Radiosurgery Dose Tolerances of the Optic Pathways. , 2018, International journal of radiation oncology, biology, physics.

[155]  G. Ying,et al.  Factors Associated with Occurrence of Radiation-induced Optic Neuropathy at “Safe” Radiation Dosage , 2018, Seminars in ophthalmology.

[156]  T. Zhou,et al.  Conformal Radiation Therapy for Pediatric Ependymoma, Chemotherapy for Incompletely Resected Ependymoma, and Observation for Completely Resected, Supratentorial Ependymoma. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[157]  R. Huddart,et al.  MRE 11 as a predictive biomarker of outcome following radiotherapy in bladder cancer , 2019 .

[158]  A Jackson,et al.  Pediatric Normal Tissue Effects in the Clinic (PENTEC): An International Collaboration to Analyse Normal Tissue Radiation Dose-Volume Response Relationships for Paediatric Cancer Patients. , 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

[159]  Martin Glas,et al.  Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial , 2019, The Lancet.